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Current pharmacotherapies and surgical intervention provide
limited benefit in the treatment of neural injuries or halt-
ing disease progression. Significant advances in the area of
stem cell biology in the last decade has lead to a special
emphasis on the success of stem cell-based applications for
the diagnosis and treatment of neurological conditions. The
properties of stem cells render them appropriate for endoge-
nous repair, disease modeling, high-throughput drug screening
and development as well as neural transplantation procedures.
Such applications will aide in increasing our knowledge and
developing treatments for neurodegenerative disorders such as
Parkinson’s disease and Huntington’s diseases as well as neu-
ral traumas including ischemic brain damage and traumatic
brain injury. This Frontiers Research topic incorporates con-
tributions from the general field of stem cell biology, with
a particular emphasis on utilizing these cells to develop new
therapies for neural repair. Related articles deal with issues
including: promoting endogenous neurogenesis, breakthroughs
in stem cell differentiation methodologies, using pluripotent
and neural stem cells for transplantation, patient derived stem
cells for disease modeling and using stem cells for drug
discovery.
The first 3 papers focus on understanding and subsequently
exploiting, endogenous neurogenesis in order to enhance neu-
ral repair. Within the adult mammalian brain, neurogenesis is
largely restricted to two sites; the dentate gyrus of the hip-
pocampus and the subventricular zone adjacent to the lateral
ventricle. In order to “harness” these cells for repair it will
be vital to understand the mechanisms regulating their pro-
liferation, migration, differentiation and survival. Sui et al.
(2013) examines the role of the neuropeptide cholecystokinin
(CCK) and its receptor (CCK1R) in this context. It is now
well recognized that existing rates of neurogenesis in the adult
brain are insufficient to replace neurons lost to neurodegen-
eration or trauma. Taylor et al. (2013) provide an overview
of the field of hippocampal neurogenesis, the consequences
of ageing on these populations, as well as changes in mood-
related disorders and touches on efforts to activate this largely
quiescent cell population. Christie and Turnley (2013) pro-
vide a broader review of extrinsic and intrinsic factors that
have been shown to regulate adult neurogenesis, and high-
light those that have already shown evidence of preclinical
efficacy.
The generation of stem cell lines provides valuable tools
for disease modeling and drug development. Blastocyst screen-
ing for genetic disorders such as Huntington’s disease and
Down’s syndrome have enabled the generation of embryonic
stem cells carrying these mutations. In more recent years,
inducible pluripotent stem (iPS) cell technology has allowed
stem cell lines to be generated from somatic cells of patients
suffering from a number of degenerative conditions including
Parkinson’s disease and motor neuron disease. Added to this
has been the ability to generate neural stem cell lines from
other sources such as olfactory ensheathing cells of patients.
Combined, such cell lines provide new tools to examine the
pathological events that lead to disease onset and progres-
sion as well as development and testing of novel drug tar-
gets. Here, Niclis et al. (2013) examines 2 Huntington disease
derived ESC lines. Whilst they demonstrate these lines show
many normal properties, including gene expression, that are
typically dysregulated in the disease, subtle changes that may
shed further insight into the disease are observed. An arti-
cle by Mackay-Sim (2013) provides a review on the use of
stem cells for high throughput, and high content screening
of large chemical libraries in efforts to identify novel drug
targets. Such targets can then be utilized for drug develop-
ment and again tested on patient-derived stem cell lines in
culture.
One of the most widely anticipated applications for
pluripotent stem cells is their utilization in neural trans-
plantation procedures. This will require robust and appropriate
fate restriction into more specialized lineages and their survival
and appropriate functional integration into existing host circuitry
after transplantation. Kirkeby et al. (2013) contribute a detailed
methodological paper on the generating regionally specified
neurons, by way of controlling dorso-ventral and rostrocaudal
patterning of stem cells. Arber and Li (2013) provide a more
focused review of the literature on understanding cortical
interneuron development and the progress in protocols to yield
interneuron subpopulations from pluripotent stem cells for
the purpose of transplantation into models of epilepsy. In an
original research article, Yoshikawa et al. (2013) examine the
potential of 2 commonly used anti-convulsant drugs to improve
the differentiation and survival of iPSC-derived dopaminer-
gic neurons in vitro and in vivo, with this knowledge having
implications for improved grafting approaches for treatment of
Parkinson’s disease. Garcia et al. (2013) highlight advancement
in tools and technology that enable us to more accurately assess
the integration of transplanted neurons in the brain. Finally,
Broughton et al. (2013) provide a review on the exogenous
“chaperone” benefits that stem cell grafts may provide in neural
repair. The focus of their review is on amnion cells; highlighting
the non-tumorogenic, non-immunogenic and trophic benefits of
an alternative stem cell source.
Frontiers in Cellular Neuroscience www.frontiersin.org November 2013 | Volume 7 | Article 198 | 1
CELLULAR NEUROSCIENCE
Parish and Thompson Stem cells in neural repair
Collectively these works highlight the rapidly pro-
gressing stem cell field and draw attention to the cur-
rent and on-going potential these cells have for improv-
ing our understanding of the healthy and diseased
nervous system and their capacity to promote neural
repair.
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